Management Board

Graham Watson – Chairperson

Graham Watson LLB CA FRSA is an experienced non-executive director with a strong commercial track record. He has a rich mix of recent non-executive and advisory responsibilities in Scotland, covering The Law Society of Scotland (where he is a member of Council), the Court of Heriot-Watt University (where he also chairs the Finance Committee), Scottish Futures Trust and North Lanarkshire Leisure Limited (where he also chaired the Audit Committee). He is a former partner in a Big 4 accounting firm, with extensive experience of working with SME clients delivering business development and strategic planning programmes and leading change initiatives. During his career, he has initiated and executed over 100 corporate transactions, valued at over £2bn. He has lived and worked in Silicon Valley, as well as in Scotland, during his 35-year business career.

Font Awesome Icons

Dr David Brennan, Chief Executive Officer

David Brennan has worked as a clinical scientist for 20 years specialising in Clinical Physics. During that time he has had experience in clinical research and service development. His focus has been in the field of MRI, image analysis and their clinical applications. He is a founding researcher of Aurum Biosciences having provided significant input into the development of the imaging and image analysis. During the course of Aurum’s development David has taken a keen interest in the commercial aspects of the project. He was fortunate enough to have been a student on Cambridge University’s Ignite entrepreneurial course, and MIT’s Entrepreneurship Development Program

Font Awesome Icons

Dr Celestine Santosh, Chief Medical and Scientific Officer

Celestine Santosh is a Clinical Consultant Neuroradiologist working in Glasgow, which is one of the largest Neurosciences Unit within the UK. Having started in Clinical Radiology 33 years ago, he then specialised in Neuroradiology over the last 27 years. He has worked in many large specialised hospitals in India and the UK and has been in Glasgow since 2000. He conceived the Glasgow Oxygen Dependent (GOLD) techniques working as a clinician, with a special interest in stroke. This allowed him to understand the need to accurately assess the Penumbra with imaging and also the need for additional treatments for stroke. He was successful with the team, in getting grants and funding for the pre-clinical work. Dr Santosh is a co-founder of Aurum Biosciences Ltd, a practicing clinician and inventor, so in an ideal position to take the GOLD techniques into clinical practice.